Trump Aims to Cut US Drug Costs by Pegging to Prices Abroad

Trump Aims to Cut US Drug Costs by Pegging to Prices Abroad

Watch Alix and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney and Alix Steel

Today’s Podcast Features are:

Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses President Trump attempting to slash drug prices for Americans by more closely aligning their costs to lower prices paid abroad, renewing and expanding upon a failed push from his first term.

Nathan Dean, Bloomberg Intelligence Senior Policy Analyst, discusses talks between Washington and Beijing to temporarily lower tariffs and de-escalate the trade war. The tariff arrangement will see the combined 145% US levies on most Chinese imports reduced to 30% and the 125% Chinese duties on US goods will drop to 10% for three months to give the countries time to negotiate a broader agreement on trade.

James Abate, Managing Director & Chief Investment Officer, Centre Asset Management, discusses the latest on the markets. Investors betting the US-China trade reprieve marks the end to an all-out tariff war that had threatened to tip the world into a recession sent stocks rallying, while spurring a slide in defensive corners of the market from bonds to gold and haven currencies.

Brant Standridge, President, Consumer and Business Banking at Huntington Bank, discusss Huntington's expansion as banks pull back, and overall growth story. Huntington is a top-10 U.S. regional bank and a Fortune 500 company with $204 billion in assets. It’s one of the only regional banks to post growth in the first quarter of 2025, driven by increased loans and deposits, expanded net interest margin, growth of fee revenues, and rigorous expense management.

See omnystudio.com/listener for privacy information.

Avsnitt(3190)

WM's Steiner on Earnings, Generating Big Cash (Correct)(Audio)

WM's Steiner on Earnings, Generating Big Cash (Correct)(Audio)

(Corrects ticker in headline) (Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: David Steiner, CEO of Waste Management, on the company’s strong earnings, and focus to "have destiny in its own hands" by building water treatment plants to tackle leachate.See omnystudio.com/listener for privacy information.

28 Apr 201611min

Bloomberg's Sweeney, Wilson on Amazon's Blowout Earnings(Audio)

Bloomberg's Sweeney, Wilson on Amazon's Blowout Earnings(Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. Guest: Paul Sweeney, Director of North American Research and Media analyst for Bloomberg Intelligence, and David Wilson, Bloomberg stocks editor, discuss Amazon's blowout earnings, aided by the growth of its profitable cloud business.See omnystudio.com/listener for privacy information.

28 Apr 201612min

Caprock's Weatherley-White: Plotting for Post-Carbon Era(Audio)

Caprock's Weatherley-White: Plotting for Post-Carbon Era(Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Matthew Weatherley-White, Managing director of The Caprock Group and the architect of their Impact Platform, discusses the energy landscape and the emerging outline of a post-carbon era.See omnystudio.com/listener for privacy information.

28 Apr 20168min

Standard Life's Morris Likes Rockwell Collins, Schwab (Audio)

Standard Life's Morris Likes Rockwell Collins, Schwab (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Jeff Morris, Head of US Equities at Standard Life Investments, on US Equities, focusing on banking, industrial, and aerospace/defense stocks.See omnystudio.com/listener for privacy information.

28 Apr 201611min

Bloomberg's Halperin on Trump's Appeal: People Like Fun (Audio)

Bloomberg's Halperin on Trump's Appeal: People Like Fun (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010GUEST:\u0010Mark Halperin, co-author of “Game Change” and host of Bloomberg TV’s “With All Due Respect,” highlights political news: Boehner won't back "Lucifer" Cruz; the deal to stop Trump may be backfiring; Carly Fiorina joining Ted Cruz.See omnystudio.com/listener for privacy information.

28 Apr 20166min

Bloomberg's Damouni on Abbott's 'Transformational' Deal (Audio)

Bloomberg's Damouni on Abbott's 'Transformational' Deal (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010GUEST:\u0010Sasha Damouni, Bloomberg First Word Health Care reporter, on Abbott buying St Jude Medical for $25 Billion in a record deal.See omnystudio.com/listener for privacy information.

28 Apr 20163min

Populärt inom Business & ekonomi

framgangspodden
varvet
badfluence
uppgang-och-fall
rss-borsens-finest
svd-ledarredaktionen
avanzapodden
lastbilspodden
rikatillsammans-om-privatekonomi-rikedom-i-livet
rss-kort-lang-analyspodden-fran-di
rss-dagen-med-di
fill-or-kill
affarsvarlden
borsmorgon
dynastin
kapitalet-en-podd-om-ekonomi
tabberaset
montrosepodden
borslunch-2
rss-inga-dumma-fragor-om-pengar